Vitamin D deficiency associated with a poorer response to HCV treatment in HIV/HCV-co-infected patients
Higher levels of adherence to hepatitis C therapy improve treatment outcomes in people with hepatitis C and HIV
Switching to tenofovir suppresses hepatitis B in HIV/HBV co-infected people
Sofosbuvir appears safe and effective for HIV/HCV co-infected people
Bacterial translocation is associated with more severe liver fibrosis in HIV/hepatitis C-co-infected people
Hepatitis B vaccine is effective for up to 15 years
